173 related articles for article (PubMed ID: 35513484)
1. Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration.
Khunluck T; Lertsuwan K; Chutoe C; Sooksawanwit S; Inson I; Teerapornpuntakit J; Tohtong R; Charoenphandhu N
Sci Rep; 2022 May; 12(1):7398. PubMed ID: 35513484
[TBL] [Abstract][Full Text] [Related]
2. Anti-cancer effects of selective cannabinoid agonists in pancreatic and breast cancer cells.
Turgut NH; Armagan G; Kasapligil G; Erdogan MA
Bratisl Lek Listy; 2022; 123(11):813-821. PubMed ID: 36254639
[TBL] [Abstract][Full Text] [Related]
3. The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.
Du WW; Fang L; Yang W; Sheng W; Zhang Y; Seth A; Yang BB; Yee AJ
BMC Cancer; 2012 Aug; 12():341. PubMed ID: 22862967
[TBL] [Abstract][Full Text] [Related]
4. Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.
Chen YC; Sosnoski DM; Gandhi UH; Novinger LJ; Prabhu KS; Mastro AM
Carcinogenesis; 2009 Nov; 30(11):1941-8. PubMed ID: 19759193
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of n-3 EPA and DHA and their endocannabinoid derivatives on breast cancer cell growth and invasion.
Brown I; Lee J; Sneddon AA; Cascio MG; Pertwee RG; Wahle KWJ; Rotondo D; Heys SD
Prostaglandins Leukot Essent Fatty Acids; 2020 May; 156():102024. PubMed ID: 31679810
[TBL] [Abstract][Full Text] [Related]
6. Role of cannabinoid and vanilloid receptors in invasion of human breast carcinoma cells.
Farsandaj N; Ghahremani MH; Ostad SN
J Environ Pathol Toxicol Oncol; 2012; 31(4):377-87. PubMed ID: 23394450
[TBL] [Abstract][Full Text] [Related]
7. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
[TBL] [Abstract][Full Text] [Related]
8. Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis.
Sophocleous A; Marino S; Logan JG; Mollat P; Ralston SH; Idris AI
J Biol Chem; 2015 Sep; 290(36):22049-60. PubMed ID: 26195631
[TBL] [Abstract][Full Text] [Related]
9. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
10. Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.
Bussard KM; Venzon DJ; Mastro AM
J Cell Biochem; 2010 Dec; 111(5):1138-48. PubMed ID: 20683902
[TBL] [Abstract][Full Text] [Related]
11. The flavonoid p-hydroxycinnamic acid mediates anticancer effects on MDA-MB-231 human breast cancer cells in vitro: Implications for suppression of bone metastases.
Yamaguchi M; Murata T; Shoji M; Weitzmann MN
Int J Oncol; 2015 Oct; 47(4):1563-71. PubMed ID: 26238204
[TBL] [Abstract][Full Text] [Related]
12. Metastatic breast cancer cells suppress osteoblast adhesion and differentiation.
Mercer RR; Miyasaka C; Mastro AM
Clin Exp Metastasis; 2004; 21(5):427-35. PubMed ID: 15672867
[TBL] [Abstract][Full Text] [Related]
13. Anandamide inhibits adhesion and migration of breast cancer cells.
Grimaldi C; Pisanti S; Laezza C; Malfitano AM; Santoro A; Vitale M; Caruso MG; Notarnicola M; Iacuzzo I; Portella G; Di Marzo V; Bifulco M
Exp Cell Res; 2006 Feb; 312(4):363-73. PubMed ID: 16343481
[TBL] [Abstract][Full Text] [Related]
14. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.
Maroufi NF; Vahedian V; Akbarzadeh M; Mohammadian M; Zahedi M; Isazadeh A; Pouremamali F; Taefehshokr S; Heidari M; Rashidi M; Nouri M
Breast Cancer; 2020 Jul; 27(4):613-620. PubMed ID: 32026267
[TBL] [Abstract][Full Text] [Related]
15. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy cytotoxicity of human MCF-7 and MDA-MB 231 breast cancer cells is altered by osteoblast-derived growth factors.
Koutsilieris M; Reyes-Moreno C; Choki I; Sourla A; Doillon C; Pavlidis N
Mol Med; 1999 Feb; 5(2):86-97. PubMed ID: 10203574
[TBL] [Abstract][Full Text] [Related]
17. Osteoblasts-derived TGF-beta1 enhance motility and integrin upregulation through Akt, ERK, and NF-kappaB-dependent pathway in human breast cancer cells.
Wei YY; Chen YJ; Hsiao YC; Huang YC; Lai TH; Tang CH
Mol Carcinog; 2008 Jul; 47(7):526-37. PubMed ID: 18161870
[TBL] [Abstract][Full Text] [Related]
18. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
[TBL] [Abstract][Full Text] [Related]
19. Pre-osteoblastic MC3T3-E1 cells promote breast cancer growth in bone in a murine xenograft model.
Bodenstine TM; Beck BH; Cao X; Cook LM; Ismail A; Powers SJ; Powers JK; Mastro AM; Welch DR
Chin J Cancer; 2011 Mar; 30(3):189-96. PubMed ID: 21352696
[TBL] [Abstract][Full Text] [Related]
20. Gentian violet inhibits MDA-MB-231 human breast cancer cell proliferation, and reverses the stimulation of osteoclastogenesis and suppression of osteoblast activity induced by cancer cells.
Yamaguchi M; Vikulina T; Weitzmann MN
Oncol Rep; 2015 Oct; 34(4):2156-62. PubMed ID: 26260090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
